Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
Anna Aldehag, Head of Unit of National Donation Center at Stockholm County, shared on LinkedIn:
”Thank you for the past year – and thank you for me!
Now that it is time to take stock, not only of the past year but of the years that have passed, I feel both sadness and anticipation.
After more than four years as head of unit at NDC and a total of twelve years at the National Board of Health and Welfare, it is now time to hand over the reins.
I am extremely proud of the work that has been done under my leadership, including:
• Promotion of pediatric organ donation – Knowledge support with national recommendations
• Guidance for healthcare providers on donation – About accommodating the individual’s willingness to donate and the conditions for organ preservation treatment
• Connecting the Donation Registry to 1177.se
• The Donation Guide, which recently celebrated its first anniversary
• Sweden’s first action plan for organ and tissue donation
• Developments in the field of blood with individual-based risk assessment, NAT testing, and the plasma assignment
• Registry work in the field of gamete donation and the start of the important work on a future digital national knowledge support system
• Our preparations for the role of national competent authority in the field of human materials.
A warm thank you to everyone at the National Board of Health and Welfare (Socialstyrelsen), to my colleagues in management, and to my fantastic co-workers.
Thank you also to those involved in donation and transplantation, as well as to patient and interest organizations.
I am deeply impressed by the commitment and work being done in this area.
Finally, I would like to wish you all a very Merry Christmas and a Happy New Year!
Sharing some photos from yesterday’s Christmas party and farewell with the unit, as well as two photo collages that reflect this year’s work and efforts.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026